CA2290974C - Solubilized sertraline compositions - Google Patents

Solubilized sertraline compositions Download PDF

Info

Publication number: CA2290974C
Authority: CA; Canada
Prior art keywords: composition; sertraline; matter; solubilizing agent; concentration
Prior art date: 1997-07-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA002290974A

Other languages

English (en)

French (fr)

Other versions

CA2290974A1 (en

Inventor

Dwayne Thomas Friesen

Scott Max Herbig

Ravi Mysore Shanker

James Blair West

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Products Inc

Original Assignee

Pfizer Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-15

Publication date

2004-04-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2290974(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-15 Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc

1999-01-14 Publication of CA2290974A1 publication Critical patent/CA2290974A1/en

2004-04-27 Application granted granted Critical

2004-04-27 Publication of CA2290974C publication Critical patent/CA2290974C/en

2018-06-15 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

CA002290974A 1997-07-01 1998-06-15 Solubilized sertraline compositions Expired - Fee Related CA2290974C (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US5141397P	1997-07-01	1997-07-01
US60/051,413		1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en)	1997-07-01	1998-06-15	Solubilized sertraline compositions

Publications (2)

Publication Number	Publication Date
CA2290974A1 CA2290974A1 (en)	1999-01-14
CA2290974C true CA2290974C (en)	2004-04-27

Family

ID=21971159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002290974A Expired - Fee Related CA2290974C (en)	1997-07-01	1998-06-15	Solubilized sertraline compositions

Country Status (34)

Country	Link
EP (1)	EP0999829A1 (es)
JP (1)	JP2000514100A (es)
KR (1)	KR100366373B1 (es)
CN (1)	CN1261794A (es)
AP (1)	AP1192A (es)
AR (3)	AR015917A1 (es)
AU (1)	AU742535B2 (es)
BG (1)	BG103918A (es)
BR (1)	BR9810739A (es)
CA (1)	CA2290974C (es)
CO (1)	CO4940495A1 (es)
DZ (1)	DZ2548A1 (es)
EA (1)	EA002481B1 (es)
HN (1)	HN1998000102A (es)
HR (1)	HRP980377A2 (es)
HU (1)	HUP0002236A3 (es)
ID (1)	ID23429A (es)
IL (1)	IL133076A (es)
IS (1)	IS5260A (es)
MA (1)	MA24587A1 (es)
NO (1)	NO996520L (es)
OA (1)	OA11243A (es)
PA (1)	PA8454301A1 (es)
PE (1)	PE97199A1 (es)
PL (1)	PL337804A1 (es)
SK (1)	SK181099A3 (es)
TN (1)	TNSN98124A1 (es)
TR (1)	TR199903297T2 (es)
TW (1)	TW550087B (es)
UA (1)	UA67741C2 (es)
UY (1)	UY25071A1 (es)
WO (1)	WO1999001120A1 (es)
YU (1)	YU68299A (es)
ZA (1)	ZA985708B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003518485A (ja)	1999-12-23	2003-06-10	ファイザー・プロダクツ・インク	向上された薬物濃度を与える医薬組成物
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
WO2002017918A2 (en)	2000-08-30	2002-03-07	Pfizer Products Inc.	Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101500020B1 (ko) *	2007-03-12	2015-03-06	디에스엠 아이피 어셋츠 비.브이.	미용 조성물
EP2520299A1 (en) *	2009-12-29	2012-11-07	Kowa Co., Ltd.	Solid pharmaceutical composition for oral administration
EP2520300A4 (en) *	2009-12-29	2013-05-08	Kowa Co	PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺
CN114894736A (zh) *	2022-05-20	2022-08-12	中化地质矿山总局地质研究院	一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
EP0415612B1 (en) *	1989-08-30	1993-11-10	Pfizer Inc.	Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/en not_active Expired - Fee Related
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active IP Right Cessation
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/en not_active Application Discontinuation
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/en not_active Withdrawn
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/xx active
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
2003
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown

Also Published As

Publication number	Publication date
MA24587A1 (fr)	1998-12-31
UY25071A1 (es)	2000-12-29
OA11243A (en)	2003-07-24
UA67741C2 (uk)	2004-07-15
AR015917A1 (es)	2001-05-30
EP0999829A1 (en)	2000-05-17
WO1999001120A1 (en)	1999-01-14
PE97199A1 (es)	1999-10-05
IL133076A (en)	2003-12-10
HUP0002236A3 (en)	2003-12-29
EA199900962A1 (ru)	2000-08-28
CA2290974A1 (en)	1999-01-14
AU742535B2 (en)	2002-01-03
PA8454301A1 (es)	2000-09-29
BG103918A (en)	2000-07-31
TR199903297T2 (xx)	2000-07-21
PL337804A1 (en)	2000-09-11
DZ2548A1 (fr)	2003-02-08
AR040280A2 (es)	2005-03-23
JP2000514100A (ja)	2000-10-24
YU68299A (sh)	2002-06-19
ZA985708B (en)	2000-01-10
IS5260A (is)	1999-11-19
CO4940495A1 (es)	2000-07-24
BR9810739A (pt)	2000-09-12
KR20010013365A (ko)	2001-02-26
HUP0002236A2 (hu)	2003-08-28
AR040279A2 (es)	2005-03-23
AP9801280A0 (en)	1998-06-30
TW550087B (en)	2003-09-01
SK181099A3 (en)	2000-07-11
NO996520L (no)	2000-02-29
HN1998000102A (es)	1999-01-08
IL133076A0 (en)	2001-03-19
TNSN98124A1 (fr)	2005-03-15
NO996520D0 (no)	1999-12-28
EA002481B1 (ru)	2002-06-27
AP1192A (en)	2003-07-23
KR100366373B1 (ko)	2003-01-14
ID23429A (id)	2000-04-20
HRP980377A2 (en)	1999-04-30
AU7544898A (en)	1999-01-25
CN1261794A (zh)	2000-08-02

Publication	Publication Date	Title
JP3382950B2 (ja)	2003-03-04	医薬品用の徐放性マトリックス
US5670171A (en)	1997-09-23	Liquid-suspension controlled-release pharmaceutical composition
US4798725A (en)	1989-01-17	Sustained release capsule
JP4637338B2 (ja)	2011-02-23	シロスタゾール有核錠
US4772473A (en)	1988-09-20	Nitrofurantoin dosage form
ES2405404T3 (es)	2013-05-31	Composiciones farmacéuticas de liberación sostenida que comprenden aplindore y sus derivados
KR20010012857A (ko)	2001-02-26	개선된 약물 전달용 위장체류 방출조절 미소립자
PT1492511E (pt)	2009-04-09	Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
JP2002080398A (ja)	2002-03-19	ｐＨに依存する多相的な放出を伴う経口用の固体の薬学的組成物
JP2010163455A (ja)	2010-07-29	活性成分放出制御薬物製剤
JP2003513882A (ja)	2003-04-15	ジバルプロエックスナトリウムの制御放出製剤
RU2237480C2 (ru)	2004-10-10	Непосредственно прессуемая матрица для регулируемого высвобождения однократных ежедневных доз кларитромицина
PT1492531E (pt)	2008-12-10	Formulação farmacêutica oral sob a forma de suspensão aquosa de microcápsulas que permite a libertação modificada de amoxicilina
CA2290974C (en)	2004-04-27	Solubilized sertraline compositions
ES2852899T3 (es)	2021-09-14	Formulaciones estabilizadas de molindona
US7063864B1 (en)	2006-06-20	Morphine sulphate microgranules, method for preparing same and compositions containing same
ES2321908T3 (es)	2009-06-15	Preparaciones farmaceuticas de liberacion prolongada independientemente del ph.
AU7545198A (en)	1999-01-25	Delayed-release dosage forms of sertraline
EP3288549A1 (en)	2018-03-07	Oral liquid compositions of guanfacine
JP2002509887A (ja)	2002-04-02	セファクロル含有徐放性組成物
WO2020157730A1 (en)	2020-08-06	A controlled release pharmaceutical composition of selexipag or it's active metabolite
JPH069388A (ja)	1994-01-18	徐放性塩酸オキシブチニン製剤
JPH0748256A (ja)	1995-02-21	ニセルゴリンを含有する制御放出性の製薬組成物
PT1618873E (pt)	2007-09-04	Grânulos para libertação controlada de tamsulosina, que contém alginato.
US20040208926A1 (en)	2004-10-21	Solubilized sertraline compositions

Legal Events

Date	Code	Title	Description
1999-11-25	EEER	Examination request
2008-06-16	MKLA	Lapsed